• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

溶菌性分枝杆菌噬菌体D29对结核分枝杆菌感染的巨噬细胞RAW 264细胞系模型的效率评估。

Evaluation of the Efficiency of Lytic Mycobacteriophage D29 on the Model of M. tuberculosis-Infected Macrophage RAW 264 Cell Line.

作者信息

Lapenkova M B, Smirnova N S, Rutkevich P N, Vladimirsky M A

机构信息

Research Institute of Phthisiopulmonology, I. M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation, Moscow, Russia.

Research Institute of Experimental Cardiology, Russian Cardiology Research and Production Complex, Ministry of Health of the Russian Federation, Moscow, Russia.

出版信息

Bull Exp Biol Med. 2018 Jan;164(3):344-346. doi: 10.1007/s10517-018-3986-0. Epub 2018 Jan 8.

DOI:10.1007/s10517-018-3986-0
PMID:29313233
Abstract

Culture of mouse macrophages (RAW 264.7 ATCC strain) in wells of a 6-well plate was infected with M. tuberculosis in proportion of 15 mycobacteria per one macrophage and then treated with a lytic strain of mycobacteriophage D29. Antibacterial efficacy of mycobacteriophages was studied using D29 phage (activity 108 plaque-forming units/ml) previously purified by ion exchange chromatography. After single and double 24-h treatment, the lysed cultures of macrophages were inoculated onto Middlebrook 7H10 agar medium. The number of mycobacterial colonies in control and test wells (at least 3 wells in each group) was 300.178±12.500 and 36.0±5.4, respectively (p<0.01).

摘要

将小鼠巨噬细胞(RAW 264.7 ATCC菌株)接种于6孔板的孔中,以每一个巨噬细胞对应15个分枝杆菌的比例感染结核分枝杆菌,然后用裂解性分枝杆菌噬菌体D29进行处理。使用先前通过离子交换色谱法纯化的D29噬菌体(活性为108噬菌斑形成单位/毫升)研究分枝杆菌噬菌体的抗菌效果。在进行单次和两次24小时处理后,将裂解的巨噬细胞培养物接种到Middlebrook 7H10琼脂培养基上。对照孔和测试孔(每组至少3个孔)中的分枝杆菌菌落数分别为300.178±12.500和36.0±5.4(p<0.01)。

相似文献

1
Evaluation of the Efficiency of Lytic Mycobacteriophage D29 on the Model of M. tuberculosis-Infected Macrophage RAW 264 Cell Line.溶菌性分枝杆菌噬菌体D29对结核分枝杆菌感染的巨噬细胞RAW 264细胞系模型的效率评估。
Bull Exp Biol Med. 2018 Jan;164(3):344-346. doi: 10.1007/s10517-018-3986-0. Epub 2018 Jan 8.
2
Bactericidal Activity of Liposomal Form of Lytic Mycobacteriophage D29 in Cell Models of Tuberculosis Infection In Vitro.脂质体形式的裂解分枝杆菌噬菌体 D29 在体外结核感染细胞模型中的杀菌活性。
Bull Exp Biol Med. 2020 Jul;169(3):361-364. doi: 10.1007/s10517-020-04887-6. Epub 2020 Aug 3.
3
Mycobacteriophage D29 induced association of Mycobacterial RNA polymerase with ancillary factors leads to increased transcriptional activity.分枝杆菌噬菌体 D29 诱导分枝杆菌 RNA 聚合酶与辅助因子的关联,导致转录活性增加。
Microbiology (Reading). 2022 Mar;168(3). doi: 10.1099/mic.0.001158.
4
A high yielding mutant of mycobacteriophage L1 and its application as a diagnostic tool.分枝杆菌噬菌体L1的高产突变体及其作为诊断工具的应用。
FEMS Microbiol Lett. 2000 Jul 1;188(1):47-53. doi: 10.1111/j.1574-6968.2000.tb09167.x.
5
Different characteristics between mycobacteriophage Chy1 and D29, which were classified as cluster A2 mycobacteriophages.分枝杆菌噬菌体Chy1和D29之间的不同特征,它们被归类为A2群分枝杆菌噬菌体。
Indian J Med Microbiol. 2016 Apr-Jun;34(2):186-92. doi: 10.4103/0255-0857.180282.
6
Killing of Mycobacterium avium and Mycobacterium tuberculosis by a mycobacteriophage delivered by a nonvirulent mycobacterium: a model for phage therapy of intracellular bacterial pathogens.由无毒分枝杆菌递送的分枝杆菌噬菌体对鸟分枝杆菌和结核分枝杆菌的杀伤作用:细胞内细菌病原体噬菌体疗法的模型
J Infect Dis. 2002 Oct 15;186(8):1155-60. doi: 10.1086/343812. Epub 2002 Sep 30.
7
In vivo efficacy of phage therapy for Mycobacterium avium infection as delivered by a nonvirulent mycobacterium.非致病性分枝杆菌递送的噬菌体疗法对鸟分枝杆菌感染的体内疗效。
Microb Drug Resist. 2006 Spring;12(1):1-6. doi: 10.1089/mdr.2006.12.1.
8
Construing the function of N-terminal domain of D29 mycobacteriophage LysA endolysin in phage lytic efficiency and proliferation.构建 D29 分枝杆菌噬菌体 LysA 内溶素 N 端结构域在噬菌体裂解效率和增殖中的功能。
Mol Microbiol. 2024 Aug;122(2):243-254. doi: 10.1111/mmi.15295. Epub 2024 Jul 12.
9
Comparison of several culture media used for studies on mycobacteriophages.几种用于分枝杆菌噬菌体研究的培养基的比较。
J Med Microbiol. 1978 May;11(2):187-91. doi: 10.1099/00222615-11-2-187.
10
Mycobacteriophage D29 Lysin B exhibits promising anti-mycobacterial activity against drug-resistant .分枝杆菌噬菌体 D29 溶菌酶 B 对耐药性. 具有有前景的抗分枝杆菌活性。
Microbiol Spectr. 2023 Dec 12;11(6):e0459722. doi: 10.1128/spectrum.04597-22. Epub 2023 Oct 6.

引用本文的文献

1
Human Gut Bacteriophageome: Insights Into Drug Resistance Mechanisms in Tuberculosis.人类肠道噬菌体组:对结核病耐药机制的见解
Interdiscip Perspect Infect Dis. 2025 Jun 16;2025:8811027. doi: 10.1155/ipid/8811027. eCollection 2025.
2
Activity of Bacteriophage D29 Loaded on Nanoliposomes against Macrophages Infected with .负载于纳米脂质体上的噬菌体D29对感染……的巨噬细胞的活性
Diseases. 2023 Oct 26;11(4):150. doi: 10.3390/diseases11040150.
3
Experimental Studies of the Liposomal Form of Lytic Mycobacteriophage D29 for the Treatment of Tuberculosis Infection.
用于治疗结核感染的裂解性分枝杆菌噬菌体D29脂质体形式的实验研究
Microorganisms. 2023 May 5;11(5):1214. doi: 10.3390/microorganisms11051214.
4
Bacteriophage Therapy of Bacterial Infections: The Rediscovered Frontier.细菌感染的噬菌体疗法:重新发现的前沿领域。
Pharmaceuticals (Basel). 2021 Jan 5;14(1):34. doi: 10.3390/ph14010034.
5
Mycobacteriophages as Potential Therapeutic Agents against Drug-Resistant Tuberculosis.分枝杆菌噬菌体作为治疗耐药性结核病的潜在治疗剂。
Int J Mol Sci. 2021 Jan 13;22(2):735. doi: 10.3390/ijms22020735.
6
Antimycobacterial Potential of Mycobacteriophage Under Disease-Mimicking Conditions.疾病模拟条件下分枝杆菌噬菌体的抗分枝杆菌潜力
Front Microbiol. 2020 Dec 14;11:583661. doi: 10.3389/fmicb.2020.583661. eCollection 2020.
7
Atmospheric Spray Freeze Drying of Sugar Solution With Phage D29.用噬菌体D29对糖溶液进行常压喷雾冷冻干燥。
Front Microbiol. 2019 Mar 20;10:488. doi: 10.3389/fmicb.2019.00488. eCollection 2019.